If you need more lookups,
subscriptions start at $34 USD/month.
Michael Ferrari Location
Garden City, NY, US
Michael Ferrari Work
Chief Revenue Officer - US Institutional and Consulting @ (May 2021 - Present)
Head of New Business Development: Focused on driving new sales revenue and managing sales strategy @ (March 2004 - Present)
Founder and Director @ Pathogenics, Inc. (January 2002 - February 2004)
Vice President, Business Development @ Atlantic Technology Ventures (January 2001 - April 2003)
Technology Associate @ Paramount Capital Investments, LLC / Corporate Technology Development, Inc. (August 1998 - December 2000)
Sales Associate @ Aetna US Healthcare (August 1997 - August 1998)
Michael Ferrari Education
Villanova University
Bachelor of Science (B.S.) (Biology, General)
1993-1997
Michael Ferrari Skills
Account Management
Business Development
Business Strategy
CRM
Competitive Analysis
Competitive Intelligence
Entrepreneurship
Financial Services
Hedge Funds
Investments
Leadership
Market Analysis
Market Research
Marketing Research
Marketing Strategy
Networking
New Business Development
Product Development
Sales
Sales Management
Salesforce.com
Selling
Start-ups
Strategic Planning
Strategy
Venture Capital
Business Analysis
Start Ups
Marketing
Startups
Customer Service
Michael Ferrari Summary
Michael Ferrari, based in Garden City, NY, US, is currently a Chief Revenue Officer - US Institutional and Consulting at Guidepoint. Michael Ferrari brings experience from previous roles at Guidepoint, Pathogenics, Inc., Atlantic Technology Ventures and Paramount Capital Investments, LLC / Corporate Technology Development, Inc.. Michael Ferrari holds a 1993 - 1997 Bachelor of Science (B.S.) in Biology, General @ Villanova University. With a robust skill set that includes Account Management, Business Development, Business Strategy, CRM, Competitive Analysis and more. Michael Ferrari has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Michael Ferrari?
Find contact details for 700 million professionals.